CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC
CONCLUSION: Increased plasma levels of EGF and Angiopoietin-1 after HDR-BT for HCC are associated with poor response and may therefore function as predictive biomarkers of outcome.PMID:38401507 | DOI:10.1016/j.tranon.2024.101919
Source: Translational Oncology - Category: Cancer & Oncology Authors: Lukas Salvermoser Shraga Nahum Goldberg Marianna Alunni-Fabbroni Philipp Maximilian Kazmierczak Moritz Nikolaus Gr öper Jan Niklas Sch äfer Elif Öcal Tanja Burkard Stefanie Corradini Najib Ben Khaled Agnese Petrera Moritz Wildgruber Jens Ricke Matthias Source Type: research
More News: Brachytherapy | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Study